Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicardipine Versus Labetalol for BP Control Before Reperfusion in Acute Ischemic Stroke
NCT07277283Phase 4Completed
- Sponsor
- Haseki Training and Research Hospital
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicardipine, labetalol in ischemic stroke, hypertensive crisis, sponsored by Haseki Training and Research Hospital. Started Feb 2025; status: completed.
02
Drugs
nicardipinelabetalol
03
Conditions
ischemic strokehypertensive crisis
Beyond the preview
Go deeper on NCT07277283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07277283.